Originally published by our sister publication Infectious Disease Special Edition
Hepatitis B virus (HBV) is a significant contributor to morbidity and mortality in people who have been diagnosed with HIV. Globally, 8% to 10% of people with HIV are coinfected with HBV, with rates of coinfection as high as 25% in regions with a high prevalence of HBV.1 In the United States, the rate is about 5% to 10%.1 In Euro-American areas, HIV is primarily